BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30347135)

  • 1. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
    Freedland SJ; Branche BL; Howard LE; Hamilton RJ; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ;
    BJU Int; 2019 Jul; 124(1):69-75. PubMed ID: 30347135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
    Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Vidal AC; Howard LE; Sun SX; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):72-78. PubMed ID: 27698439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
    Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
    World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database.
    Chang SL; Freedland SJ; Terris MK; Aronson WJ; Kane CJ; Amling CL; Presti JC
    Urology; 2010 Feb; 75(2):439-44. PubMed ID: 19819536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.
    Jayachandran J; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):9-17. PubMed ID: 20056618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, race, and long-term prostate cancer outcomes.
    Vidal AC; Oyekunle T; Howard LE; De Hoedt AM; Kane CJ; Terris MK; Cooperberg MR; Amling CL; Klaassen Z; Freedland SJ; Aronson WJ
    Cancer; 2020 Aug; 126(16):3733-3741. PubMed ID: 32497282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
    Wu C; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2013 Jun; 111(8):E310-8. PubMed ID: 23305170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.
    Pompe RS; Gild P; Karakiewicz PI; Bock LP; Schlomm T; Steuber T; Graefen M; Huland H; Tian Z; Tilki D
    Prostate; 2018 Jun; 78(9):676-681. PubMed ID: 29570821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
    van Roermund JG; Kok DE; Wildhagen MF; Kiemeney LA; Struik F; Sloot S; van Oort IM; Hulsbergen-van de Kaa CA; van Leenders GJ; Bangma CH; Witjes JA
    BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group.
    Teeter AE; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    Urology; 2013 Jul; 82(1):53-8. PubMed ID: 23806388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database.
    Kane CJ; Im R; Amling CL; Presti JC; Aronson WJ; Terris MK; Freedland SJ;
    Urology; 2010 Sep; 76(3):695-700. PubMed ID: 20394969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    Bañez LL; Sun L; Trock BJ; Han M; Partin AW; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
    Tomaszewski JJ; Chen YF; Bertolet M; Ristau BT; Woldemichael E; Nelson JB
    Urology; 2013 May; 81(5):992-6. PubMed ID: 23453649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
    Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Dorey FJ; Walsh PC; Partin AW
    JAMA; 2005 Jul; 294(4):433-9. PubMed ID: 16046649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.
    Koo KC; Yoon YE; Rha KH; Chung BH; Yang SC; Hong SJ
    Int Urol Nephrol; 2014 Oct; 46(10):1935-40. PubMed ID: 24817520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.